Graded review
Best Longevity Blood Test Services, Compared (2026)
Function, InsideTracker, Lifeforce, Superpower — graded honestly. The four cheap outcome-validated markers matter; the '100+ biomarker' count mostly doesn't.
Evidence scorecard
The one-sentence version
The "best" longevity blood test isn't the one with the most markers — it's the one that reliably surfaces the four or five cheap, outcome-validated numbers your regular checkup skips (ApoB, Lp(a) once, hs-CRP, HbA1c) and gets them in front of a clinician who will act on them. By that bar, the big DTC lab memberships — Function Health, InsideTracker, Lifeforce, Superpower — are far more alike than their marketing suggests. They differ mainly on price, panel padding, and whether they bolt on a physician or a supplement upsell. None of them clears the bar that actually matters in longevity medicine: testing is not treating. This page grades them on that honest axis. For where lab-membership testing sits in the wider field, see our pillar on longevity medicine: what's proven vs hyped, and for the marker-by-marker breakdown, what longevity biomarker panels actually test.
The category, honestly: more markers ≠ better care
Every service in this roundup sells a version of the same promise: pay an annual fee, get a big blood panel, see your numbers on a clean dashboard with "optimal" ranges, retest later in the year. The headline is always a biomarker count — 50, 100, 100-plus. That number is the least useful thing about the product.
Here's why. A standard annual physical typically orders a basic lipid panel, a metabolic panel, and a CBC, then stops. A longevity panel's genuine value is adding a handful of markers with hard-outcome evidence that the basic checkup leaves out:
- ApoB counts every atherogenic particle — one ApoB per LDL, VLDL, Lp(a), or remnant — so it measures the number of particles that can lodge in an artery wall, not just their cholesterol cargo. When ApoB and LDL-C disagree (common in metabolic syndrome and diabetes), the particle count is the better predictor of cardiovascular events1.
- Lp(a) is a genetically fixed, mostly lifelong-stable particle that independently and causally raises heart-attack and stroke risk — Mendelian-randomization data make the causal case cleanly2. You measure it once. A service that re-bills you for it every cycle is padding, not medicine.
- hs-CRP flags low-grade systemic inflammation and predicted first cardiovascular events at least as well as LDL cholesterol in a large prospective study3. (It's non-specific — a cold spikes it — so a high reading means "recheck when well.")
- HbA1c is average blood sugar over ~3 months and predicted all-cause and cardiovascular mortality continuously in a population study, with risk rising across the range, even below the diabetes threshold4.
Get those four, plus a catch of a treatable thyroid, ferritin, or vitamin-D problem, and a panel has earned its keep. Everything beyond that — the long tail of correlated markers, the "youth hormone" extras — adds line items and a feeling of completeness without adding much independent, actionable signal. Two markers worth naming as traps because nearly every padded panel features them: IGF-1, marketed as a youth hormone but with a U-shaped mortality curve (both low and high associate with higher death rates), and homocysteine, which looks treatable but whose lowering with B-vitamins failed to cut cardiovascular events in large trials. More tubes of blood is not more health.
The rule
More markers ≠ better care
- The actionable core is small and cheap: ApoB, Lp(a) (once), hs-CRP, HbA1c — outcome-validated markers most checkups skip.
- The '100+ biomarker' headline is mostly framing: roughly half is ordinary bloodwork, much of the tail is correlated padding.
- Two featured markers mislead as targets: IGF-1 (U-shaped mortality curve) and homocysteine (lowering it failed to cut events).
- Every service here tests but doesn't treat — except Lifeforce, which bundles a clinician and prescribing at a premium.
- The two biggest longevity levers — cardiorespiratory fitness and grip strength — aren't on any blood panel.
The services, graded
We'll keep this to the four most prominent DTC blood-test memberships and grade each on the only two axes that matter: does it surface the outcome-validated core, and does it do anything to treat what it finds?
Function Health — the broad panel, test-but-don't-treat
Function is the category's headline act: a ~$499/year membership built around a "100+ biomarker" baseline panel plus a mid-year retest, with physician-ordered and -reviewed labs and a dashboard that flags results against "optimal" ranges. Its real strength is that the long list does include the cheap, outcome-validated core — ApoB, Lp(a), hs-CRP, HbA1c — that most checkups skip, and surfacing them to a motivated person is genuine value. Its honest limit is that roughly half the panel is ordinary bloodwork, much of the tail is correlated padding, and — decisively — it tests without treating. It flags a high ApoB; it doesn't titrate your statin. For a motivated, health-literate buyer with a clinician who'll act, that's fine; for anyone hoping the subscription itself improves their health, it's a category error. We grade it in full in our Function Health review.
InsideTracker — DNA + blood integration, priced per-marker high
InsideTracker layers a one-time DNA component onto recurring blood panels and an algorithmic "InnerAge" plus personalized food/supplement recommendations. The blood science underneath is legitimate where it overlaps the outcome-validated core, but two honest catches define it: it is pricier per marker than Function for a comparably sized panel, and its recommendation engine skews toward supplements and add-ons — a structural conflict when the company also benefits from your acting on its nudges. It's a polished product whose "personalization" is the selling point and the caution at once. We weigh whether its DNA-plus-blood model justifies the premium in longevity clinics vs lab memberships.
Lifeforce — fewer markers, but a clinician and Rx attached
Lifeforce is the one that partly answers the test-but-don't-treat critique. For roughly $129/month plus a kit fee it runs a narrower panel (~50 markers) quarterly, but bundles a physician consult and the ability to prescribe — hormones, metabolic agents — off the results. That's a meaningfully different model: it crosses from measurement toward management. The trade-offs are a narrower panel for the price, a recurring cost that's high for the marker count, and supplement-upsell pressure baked into the membership. Whether the clinician access justifies the premium depends entirely on whether you'd actually use the prescribing. We map that membership-vs-clinic trade-off in longevity clinics vs lab memberships.
Superpower — cheap, big panel, newest and least proven
Superpower is the aggressive price disruptor: a very large baseline panel for a low annual fee (often cited around $199), positioned as "100+ labs for less." On the surface that looks like the best deal in the roundup, and for the cheap outcome-validated core it can be. The honest caveats: it is the newest and least track-recorded of the four, a low price often means more of the panel is the ordinary-bloodwork filler that inflates the count, and like Function it is structurally a test-but-don't-treat dashboard. Cheaper padding is still padding — judge it on whether the actionable core is in there and reliably run, not on the headline number.
Graded scorecard
| Service | Model & price | Honest catch | Grade |
|---|---|---|---|
| Function Health | ~$499/yr, 100+ markers + retest, physician-reviewed | Half is basic labs; tests but doesn't treat | B (core) / C (model) |
| InsideTracker | DNA + blood, InnerAge score, recurring | Pricier per marker; recs skew to supplements | C+ |
| Lifeforce | ~$129/mo + kit, ~50 markers, clinician + Rx | Narrow panel for price; upsell pressure | B− (treats, at a premium) |
| Superpower | Large panel, low fee (~$199) | Newest/least proven; more filler; doesn't treat | C+ |
How to actually choose
Strip away the marketing and the decision is small:
- You're health-literate and have a clinician who'll act on results. Pick on price for the outcome-validated core. Function or Superpower get you ApoB/Lp(a)/hs-CRP/HbA1c without a fight; pay the least for a panel that reliably includes them.
- You want testing and prescribing in one place. Lifeforce is the only one here that crosses into treatment — but you're paying a clinic-adjacent premium, so only worth it if you'll use the physician access.
- You want "personalized" guidance and don't mind upsell pressure. InsideTracker — eyes open that the recommendations lean toward products it benefits from.
- You want a biological-age number too. That's a different product with its own limits — a comprehensive blood panel is not an epigenetic-age test. See our honest take on whether biological age tests work at all and the head-to-head epigenetic clock comparison.
And before paying anyone: the open, outcome-validated PhenoAge formula derives a biological-age estimate from a basic blood draw for free, which we cover in free biological-age tests. The two single biggest longevity levers in all of epidemiology aren't even on any of these panels — cardiorespiratory fitness, among the most powerful survival predictors ever measured5, and grip strength, which outpredicted blood pressure across 17 countries in the PURE study6. No dashboard substitutes for moving them.
Bottom line
The best longevity blood test is the cheapest one that reliably surfaces ApoB, Lp(a) (once), hs-CRP, and HbA1c and gets them to a clinician who'll treat what's abnormal. By that bar Function, InsideTracker, Lifeforce, and Superpower are close cousins separated mostly by price, panel padding, and whether a physician or a supplement store is attached. Function and Superpower compete on the broad-panel-test-but-don't-treat model; Lifeforce alone bundles prescribing at a premium; InsideTracker charges more per marker and leans on supplement recommendations. None of them is itself a health intervention — surfacing a flagged number is not the same as moving an outcome. For an independently graded look at the labs and clinics selling these memberships, see our longevity clinic rankings.
Frequently asked questions
What is the best longevity blood test service?
There's no single winner — the best one is the cheapest service that reliably surfaces the outcome-validated core (ApoB, Lp(a) once, hs-CRP, HbA1c) and gets it to a clinician who'll act on abnormal results. Function Health and Superpower compete on a broad panel at lower cost; Lifeforce is the only one that bundles a physician and prescribing, at a premium; InsideTracker charges more per marker and leans on supplement recommendations. Pick on whether you're paying mainly for data (Function/Superpower) or for treatment (Lifeforce).
Are 100+ biomarker panels worth it?
The headline count is mostly marketing. A handful of markers — ApoB, Lp(a) (once), hs-CRP, HbA1c — have strong hard-outcome evidence and are skipped by most basic checkups, and surfacing them is real value. But roughly half of a '100+' panel is ordinary bloodwork available more cheaply, much of the tail correlates with the cheap core and adds little independent signal, and a couple of featured markers (IGF-1, homocysteine) actively mislead as targets. A longer panel is not a healthier one.
Which longevity blood markers actually matter?
The cheap, outcome-validated core: ApoB for cardiovascular particle risk (better than LDL-C when they disagree), Lp(a) measured once (genetically fixed, causal for heart disease), hs-CRP for inflammation, and HbA1c for metabolic risk (predicts mortality continuously). A treatable thyroid, ferritin, or vitamin-D abnormality is worth catching too. Notably, two of the strongest longevity predictors — cardiorespiratory fitness and grip strength — aren't blood tests at all, so no panel captures them.
Do any of these services treat your results, or just test them?
Most just test and flag. Function, InsideTracker, and Superpower are measurement products — they surface numbers against 'optimal' ranges, and acting on an abnormal result falls to you and your own clinician. Lifeforce is the exception: it bundles a physician consult and the ability to prescribe, crossing from measurement toward management — but you pay a clinic-adjacent premium for it. That test-but-don't-treat structure is the defining limit of the whole DTC lab category.
References
- Glavinovic T, Thanassoulis G, de Graaf J, et al. (2022). Physiological Bases for the Superiority of Apolipoprotein B Over Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk. Journal of the American Heart Association. https://pubmed.ncbi.nlm.nih.gov/36216435/
- Clarke R, Peden JF, Hopewell JC, et al. (2009). Genetic variants associated with Lp(a) lipoprotein level and coronary disease. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/20032323/
- Ridker PM, Rifai N, Rose L, et al. (2002). Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/12432042/
- Khaw KT, Wareham N, Luben R, et al. (2001). Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ. https://pubmed.ncbi.nlm.nih.gov/11141143/
- Mandsager K, Harb S, Cremer P, et al. (2018). Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing. JAMA Network Open. https://pubmed.ncbi.nlm.nih.gov/30646252/
- Leong DP, Teo KK, Rangarajan S, et al. (2015). Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet. https://pubmed.ncbi.nlm.nih.gov/25982160/
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
More graded reviews
Longevity Medicine: What's Proven vs Hyped
An honest, evidence-graded tour of the longevity toolkit — what has human outcome RCTs versus what is animal or mechanistic-only.
ReadDo NAD+ and Peptides Actually Extend Lifespan?
NAD+ precursors reliably raise NAD+ but show modest, mixed human outcomes. Peptides and growth hormone carry real cautions. An honest evidence review.
ReadRapamycin & Metformin for Longevity: The Evidence
Strong animal data, a glaring human RCT gap. What the PEARL pilot, the TAME rationale, and metformin's observational signal really show.
ReadAre Longevity Clinics Worth It?
DTC and IV longevity clinics sit on the weakest evidence in the field. What a critical review found, and how to vet a provider before paying.
ReadRapamycin for Longevity: Hype vs Evidence
Rapamycin is the most reproducible lifespan extender in mice — but there is no human longevity trial. An honest split of the hype from the evidence.
ReadLongevity Clinics vs Lab Memberships vs Rx Telehealth: What Each Delivers
The longevity market splits into four bands: concierge clinics, membership programs, DTC labs, single-product Rx. What each delivers, and who it's for.
ReadBiological Age Tests: Do Epigenetic Clocks Actually Work?
Epigenetic clocks (Horvath, GrimAge, DunedinPACE) predict aging well in populations — but are noisy and unproven for individuals. An honest evidence review.
ReadNAD+ for Longevity: What the Trials Actually Show
NR and NMN reliably raise NAD+ in humans, but the trials mostly fail to show clinical or longevity outcomes. An honest review of the hype versus the data.
ReadWhat Do Longevity Biomarker Panels Actually Test?
Longevity panels mix genuinely useful, outcome-validated markers (ApoB, HbA1c, hs-CRP) with vanity numbers. An honest, evidence-graded breakdown.
ReadGLP-1s for Healthspan & Longevity: The Evidence
GLP-1 drugs have the strongest human outcome data in longevity — but it's cardiometabolic risk reduction, not proven lifespan extension. An honest review.
ReadPeptides for Longevity: What's Real and What's Marketing
Most longevity peptides are sold on mechanism and anecdote, not human outcomes. An honest, citation-backed review of what the evidence actually supports.
ReadMetformin for Longevity: The TAME Trial Evidence
Metformin's anti-aging case is mechanistic and observational — no completed RCT proves it. Why the TAME trial exists, and the exercise caveat.
ReadConcierge vs Membership Longevity: What You Actually Get
Concierge clinics ($8k–$25k/yr) sell diagnostics; membership programs ($99–$300/mo) sell ongoing treatment. What each delivers, and where the money goes.
ReadHow We Grade Longevity Providers: Our Methodology
The five-axis rubric behind our longevity provider rankings: oversight, evidence honesty, transparency, price, and conflicts of interest.
ReadBest Longevity Supplements, Rated by Evidence (2026)
We grade the popular longevity supplements — NMN, NR, spermidine, resveratrol, CoQ10, omega-3, vitamin D, fisetin, GlyNAC — on human evidence, not hype.
ReadWhat Is a Longevity Doctor (and Do You Need One)?
A longevity doctor blends preventive medicine, biomarker testing, and lifestyle coaching. What they really do, credentials to check, and who needs one.
ReadSpermidine for Longevity: What the Evidence Shows
Spermidine induces autophagy and dietary intake tracks with lower mortality — but the best human trial was negative. An honest, evidence-graded review.
ReadThe Sitting-Rising Test & Longevity: What the Evidence Actually Shows
The sitting-rising and sit-to-stand tests predict mortality in research — but they're markers of strength, balance, and flexibility, not a verdict.
ReadHow Much Does a Longevity Clinic Cost?
Longevity care runs from ~$200/yr lab memberships to $20k+ concierge programs. A 2026 price-band guide to what each tier buys — and what's worth paying for.
ReadFree Biological-Age Tests & Calculators: Do They Actually Work?
Free biological-age calculators range from validated (PhenoAge from a basic blood panel) to entertainment. An honest guide to what's worth your time.
ReadTaurine for Longevity: Does the 2023 Science Study Hold Up?
A 2023 Science paper called taurine deficiency a driver of aging. A 2025 Science follow-up questioned its core premise. An honest, evidence-graded review.
ReadUrolithin A (Mitopure): Mitochondrial Hype or Real?
Urolithin A (Mitopure) has the cleanest human-trial record of any mitochondrial supplement — modest muscle gains in RCTs. But healthspan isn't lifespan.
ReadFisetin as a Senolytic: What "Hit-and-Run" Dosing Shows
Fisetin was the standout senolytic flavonoid in mouse screens and extended lifespan ~10%. In humans, the longevity data are essentially zero. An honest review.
ReadGlyNAC (Glycine + NAC) for Aging: What the Baylor Trials Actually Show
Baylor RCTs report GlyNAC corrects glutathione deficiency and several aging hallmarks in older adults. But the trials are small and the headlines overstate it.
ReadAlpha-Ketoglutarate (Rejuvant/AKG): Does the "8 Years Younger" Claim Hold Up?
The viral "8 years younger" AKG result came from a 42-person study with no placebo group and an unvalidated aging clock. An honest evidence review.
ReadDasatinib + Quercetin: How Far Along Is the Flagship Senolytic?
Dasatinib + quercetin is the first-in-human senolytic — with small IPF and kidney signals. But it's a chemo drug plus a flavonoid, with no longevity RCT yet.
ReadTruDiagnostic TruAge Review: Is the $229 Epigenetic Clock Worth It?
TruDiagnostic's TruAge uses the well-validated DunedinPACE clock — but no test proves the score predicts YOUR outcomes. An honest, evidence-graded review.
ReadFunction Health Review: Are 100+ Biomarkers Worth $499/yr?
Function Health's 100+ lab membership surfaces real outcome-validated markers — but roughly half are basic labs, and it tests without treating. Honest review.
ReadBryan Johnson's Blueprint Review: Evidence vs N-of-1 Hype
Bryan Johnson's Blueprint is a single-subject experiment with no control group — and roughly 90% of its likely benefit is replicable diet, sleep, and exercise.
ReadVO2 Max and Longevity: The Strongest Fitness Predictor of Lifespan
Cardiorespiratory fitness is one of the best-validated predictors of mortality — low fitness carries risk on par with smoking, and it's trainable.
ReadGrip Strength as a Longevity Biomarker: What the Evidence Shows
In the 140,000-person PURE study, grip strength outpredicted systolic blood pressure for mortality. A genuinely strong, free, at-home biomarker.
ReadFasting-Mimicking Diet (ProLon) Review: Does the Evidence Hold Up?
ProLon's 5-day fasting-mimicking diet has real human trials behind it — but most are tied to its inventor's company. An honest, graded look.
ReadHyperbaric Oxygen for Aging: Does the Telomere Claim Hold Up?
One small Israeli trial reported HBOT lengthened telomeres 38% and cut senescent cells. It's striking, unreplicated, and expensive. An honest, graded review.
ReadCreatine for Aging: The Cheapest Evidence-Backed Supplement?
Creatine has the strongest human evidence of any longevity supplement — for healthspan, not lifespan. With resistance training it adds muscle and strength.
ReadThe Hallmarks of Aging, Explained (and Why They Matter)
The hallmarks of aging are the cellular processes that drive getting old. A plain-English guide to the 2013 and 2023 framework — and why each one gets targeted.
ReadSulforaphane for Longevity: Promising Biology, Preclinical Proof
Sulforaphane from broccoli extends lifespan in worms and activates Nrf2 — but the human longevity evidence is preclinical. An honest, evidence-graded review.
ReadGlycine for Longevity: The Other Half of GlyNAC
Glycine alone extended mouse lifespan ~6% in the ITP. But the dramatic 'reverses aging' results belong to the GlyNAC combo, not solo glycine. An honest review.
ReadMicrodose Lithium for Longevity & Brain Aging: The Evidence
A 2025 Nature study tied lithium deficiency to Alzheimer's in mice. But that's mouse healthspan, not human lifespan — and lithium has a narrow safety window.
ReadErgothioneine: The "Longevity Vitamin"? An Evidence-Graded Review
Ergothioneine has a strong observational link to lower mortality — but no human trial, and the signal may just track a healthy diet. An honest grade.
ReadOmega-3 for Longevity: What the DO-HEALTH Trial Actually Shows
DO-HEALTH found 1 g/day omega-3 slowed epigenetic clocks by ~3–4 months. Real, randomized — but a small, surrogate effect. An honest evidence grade.
ReadCoQ10 & Ubiquinol for Aging: What the Evidence Actually Shows
KiSel-10 showed CoQ10 plus selenium cut cardiovascular mortality in elderly Swedes — but the benefit is CV-specific, not lifespan. An honest grade.
ReadBest Epigenetic Clock: GrimAge vs PhenoAge vs DunedinPACE
GrimAge predicts mortality, PhenoAge predicts disease, DunedinPACE measures pace of aging. No clock is validated to guide your treatment. An honest comparison.
ReadGlycanAge Review: Is the Glycan Aging Test Worth It?
GlycanAge measures IgG glycans tied to inflammation, and they move with lifestyle — but independent validation is thin and it can't localize a problem. Graded.
ReadGalleri Multi-Cancer Test Review: Is It Worth It?
Galleri's blood test can flag a cancer signal across many types — but no trial shows it saves lives, and false positives trigger costly cascades. Graded.
ReadFountain Life vs Human Longevity Inc: MRI Clinics Compared
Two whole-body-MRI longevity clinics compared. The headline isn't the price — it's the incidentaloma problem: most scary scan findings turn out to be nothing.
ReadSauna & Longevity: What the Finnish Studies Actually Show
Frequent sauna use is tied to ~40% lower all-cause mortality in Finnish men — but it's one observational cohort, not a randomized trial. An honest grade-B read.
ReadCold Plunge for Longevity: Hype vs Evidence
Cold exposure extends lifespan in worms and flies — but there's zero human lifespan data, and the human evidence is about recovery and mood, not living longer.
ReadZone 2 Training for Longevity: The Evidence, Graded Honestly
Zone 2 has a strong mitochondrial mechanism and builds the fitness that predicts lifespan — but no trial proves Zone 2 itself extends life. Graded honestly.
ReadOutlive by Peter Attia: An Evidence-Based Review
Attia's Outlive popularized Medicine 3.0 and the Four Horsemen. We grade the framework honestly: where the evidence is strong, and where it's reasoned opinion.
ReadBest At-Home Biological Age Test (2026): Honestly Graded
Blood-methylation clocks are the only defensible at-home bio-age tier; saliva and telomere kits are noisier. None proves you're aging slower. Honestly graded.
Read